Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Combining medication for dyslipidemia and insulin resistance with basic therapy improves outcomes for alopecia areata with metabolic syndrome.

Patients at dermatology specialist hospitals had lower death and readmission rates but higher treatment costs.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

SLE in ageing patients is less severe and needs careful treatment to avoid excess.

Artificial intelligence can accurately predict hair growth and treatment results in female pattern hair loss patients, with age of onset and duration being key factors.

Most children with childhood-onset lupus in Baghdad responded well to treatment, but some developed chronic kidney disease or died.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

Better understanding of wound healing is needed to develop effective treatments for chronic wounds.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

A SALT score of ≤ 20 indicates meaningful improvement in alopecia areata treatment.

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Intravenous corticosteroid therapy is effective for long-term hair regrowth in alopecia areata, and a scoring system helps predict treatment success and relapse.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

Both PRP and L-GF treatments improved hair transplant results, with L-GF being slightly better, but the difference was not significant.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Combining different treatments like fillers, collagen stimulators, botulinum toxin, and energy devices gives better facial rejuvenation results.

Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.

Gender-affirming hormone therapy affects metabolism differently based on treatment type.